Belite Bio (BLTE) Accumulated Depreciation & Amortization (2021 - 2025)

Belite Bio (BLTE) recorded quarterly Accumulated Depreciation & Amortization of $192000.0 in Q4 2025, up 540.0% quarter-over-quarter from $30000.0 in Q4 2024, and up 540.0% on a YoY basis from $30000.0 in Q4 2024.

Belite Bio (BLTE) Accumulated Depreciation & Amortization (2021 - 2025) Analysis & Trends

Belite Bio's Accumulated Depreciation & Amortization history runs 5 years deep, the most recent figure standing at $192000.0 for Q4 2025.

  • In Q4 2025, Accumulated Depreciation & Amortization rose 540.0% year-over-year to $192000.0; the TTM figure through Dec 2025 stood at $192000.0 (up 540.0% YoY), while the FY2025 annual figure was $192000.0, up 540.0% from the prior year.
  • Accumulated Depreciation & Amortization was $192000.0 for Q4 2025 at Belite Bio, up from $30000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $192000.0 in Q4 2025 to a low of -$487000.0 in Q4 2022.
  • Historically, Accumulated Depreciation & Amortization has averaged -$128800.0 across 5 years, with a median of $30000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2025: Accumulated Depreciation & Amortization sank 1136.17% in 2022, then soared 540.0% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $47000.0 in 2021, then tumbled by 1136.17% to -$487000.0 in 2022, then gained by 12.53% to -$426000.0 in 2023, then jumped by 107.04% to $30000.0 in 2024, then jumped by 540.0% to $192000.0 in 2025.
  • The last three Accumulated Depreciation & Amortization figures came in at $192000.0 (Q4 2025), $30000.0 (Q4 2024), and -$426000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 192,000.00
Dec 31, 2025 192,000.00
Dec 31, 2024 30,000.00
Dec 31, 2024 30,000.00
Dec 31, 2023 -426,000.00
Dec 31, 2023 -426,000.00
Dec 31, 2022 -487,000.00
Dec 31, 2022 -487,000.00
Dec 31, 2021 47,000.00
Dec 31, 2021 47,000.00